These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Solaiman KA; Diab MM; Abo-Elenin M Retina; 2010; 30(10):1638-45. PubMed ID: 20838357 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal anti-vascular endothelial growth factor in early pregnancy and the complex management of advance diabetic retinopathy and maculopathy during pregnancy. Sarmad A; Lip PL Acta Ophthalmol; 2016 Dec; 94(8):e812-e813. PubMed ID: 27167587 [No Abstract] [Full Text] [Related]
8. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema. Solaiman KA; Diab MM; Dabour SA Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Foveal Neovascularization in a Patient With Type 1 Diabetes. Jao K; Northey LC; Essex RW JAMA Ophthalmol; 2018 Sep; 136(9):e182584. PubMed ID: 30242368 [No Abstract] [Full Text] [Related]
10. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY. Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months. Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH; Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389 [TBL] [Abstract][Full Text] [Related]
18. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY. Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346 [TBL] [Abstract][Full Text] [Related]
19. Effect of intravitreal bevacizumab on macular and peripapillary choroidal thickness in injected and fellow eyes of patients with diabetic macular oedema. Örnek N; Örnek K; Oğurel T; Timur İE Acta Ophthalmol; 2015 Dec; 93(8):e684-6. PubMed ID: 25683321 [No Abstract] [Full Text] [Related]
20. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Jorge R; Costa RA; Calucci D; Cintra LP; Scott IU Retina; 2006; 26(9):1006-13. PubMed ID: 17151487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]